HLFNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
HERBALIFE LTD.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$13.88−0.72 (-4.93%)
Close on Oct 19, 2026
- Market cap
- $1.45B
- P/E (TTM)
- 9.0
- Dividend yield
- –
HERBALIFE LTD. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weight Management [Member] | $2.75B | $2.77B | $2.85B | $2.95B | $3.37B | $3.31B | $3.01B | $3.11B | $2.84B | $2.86B | 54.5% | -0.8% |
| Targeted Nutrition [Member] | $1.51B | $1.48B | $1.48B | $1.51B | $1.64B | $1.53B | $1.28B | $1.24B | $1.08B | $1.06B | 30.0% | +1.7% |
| Energy, Sports, and Fitness [Member] | $617.10M | $572.20M | $560.30M | $550.60M | $551.80M | $437.40M | $352.00M | $308.40M | $263.80M | $268.40M | 12.3% | +7.8% |
| Outer Nutrition [Member] | $85.00M | $83.60M | $82.50M | $85.80M | $107.80M | $111.30M | $97.30M | $91.90M | $93.90M | $110.40M | 1.7% | +1.7% |
| Literature, Promotional and Other [Member] | $79.10M | $84.90M | $87.90M | $101.10M | $136.20M | $152.90M | $136.80M | $142.20M | $144.70M | $182.30M | 1.6% | -6.8% |
| Shipping and Handling [Member] | – | – | – | – | – | – | – | $248.00M | $227.40M | $244.20M | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary Reporting Segment [Member] | $4.76B | $4.70B | $4.74B | $4.81B | $5.17B | $4.73B | $4.13B | $3.88B | $3.54B | $3.62B | 94.5% | +1.3% |
| Others [Member] | $2.03B | $2.00B | $2.03B | $2.44B | $2.80B | $2.61B | $2.33B | $2.49B | $2.28B | $2.24B | 40.2% | +1.2% |
| United States | $1.01B | $1.03B | $1.10B | $1.23B | $1.39B | $1.33B | $1.00B | $925.90M | $818.30M | $935.00M | 20.0% | -1.9% |
| India | $889.60M | $844.80M | $796.60M | $677.10M | $519.10M | $349.10M | $321.30M | – | – | – | 17.7% | +5.3% |
| Mexico | $557.70M | $538.60M | $525.00M | $474.60M | $463.70M | $436.90M | $473.60M | $467.90M | $442.70M | $446.60M | 11.1% | +3.5% |
| China | $279.10M | $297.60M | $327.40M | $391.00M | $629.50M | $809.60M | $752.00M | $1.01B | $885.90M | $868.80M | 5.5% | -6.2% |
| Vietnam | $278.20M | $283.70M | $279.00M | – | – | – | – | – | – | – | 5.5% | -1.9% |
From the segment and revenue-disaggregation notes of Herbalife's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.